NEW YORK (Reuters Health) – Whole-body (WB) scans using either magnetic resonance imaging (MRI) or positron-emission tomography (PET) with CT, both have high sensitivity and specificity in detecting…
NEW YORK (Reuters Health) – The theoretical advantage of a retrograde rather than antegrade approach to nerve sparing during robot-assisted radical prostatectomy (RARP) has been confirmed in a…
NEW YORK (Reuters Health) – After platinum failure in patients with advanced non-small-cell lung cancer, adding aflibercept to standard second-line docetaxel treatment does not improve overall survival (OS),…
NEW YORK (Reuters Health) – Using a hybrid of single-photon emission computed tomography (SPECT) and computed tomography (CT) to look for positive lymph nodes in melanoma patients helps…
NEW YORK (Reuters Health) – In the first-line treatment of advanced colorectal cancer, the combination of cediranib and chemotherapy is comparable to bevacizumab plus chemotherapy in terms of…
NEW YORK (Reuters Health) – Chemotherapy-induced delayed nausea remains a significant problem, despite the availability of second-generation antiemetics, researchers say. In a study they conducted, over half of…
NEW YORK (Reuters Health) – In advanced ovarian cancer, extensive lymph node dissection in a second-look operation does not improve survival, Italian researchers say. Their randomized trial addressed…
NEW YORK (Reuters Health) – Patients with esophageal cancer appear to have equally good survival after minimally invasive esophagectomy (MIE) or traditional open surgery, according to a new…
NEW YORK (Reuters Health) – In women with hormone-receptor-positive metastatic breast cancer, combining anastrozole and fulvestrant extends progression-free and overall survival, according to a paper released online today…
NEW YORK (Reuters Health) – Metallic stents used to relieve malignant ureteral obstruction may not perform any better than conventional polyurethane stents, according to a new study. “We…